Literature DB >> 8270117

Pathology of nonhuman spongiform encephalopathies: variations and their implications for pathogenesis.

G A Wells1.   

Abstract

Microscopic cavitation of the central nervous system (CNS) is a variable, non-specific feature of several different diseases of animals. In none, however, has it received more discussion than in scrapie, a naturally occurring disease of sheep, the clinical signs of which have been known for at least two centuries; yet consensus on the essential neurodegenerative pathology of scrapie emerged only three decades ago. The subsequent recognition of such changes in other species, including man, was a crucial factor in establishing the unifying concept of the transmissible spongiform encephalopathies (TSE). Recently these disorders have been recorded in several additional species, most significantly in domestic cattle as a foodborne epidemic. Although the TSE of animals present as infections, their pathology is confined to the CNS and has more in common with neuronal system degenerations with selective, usually symmetrical and progressive lesions, unaccompanied by inflammation. In a given host species the distribution of lesions may show variation, as in sheep scrapie or uniformity, as in bovine spongiform encephalopathy. Vacuolar or spongiform change is the most useful feature in routine diagnosis, in spite of variability in its prominence. The molecular pathology of the TSE is characterised by an abnormal isoform of a host-encoded membrane protein, the prion protein (PrP), accumulation of which is specially related to vacuolar change. There remain considerable deficits in our knowledge of the pathogenesis of the naturally occurring animal TSE, not least the extraneural events leading to CNS involvement and the relative roles of vacuolar change and PrP accumulation.

Entities:  

Mesh:

Year:  1993        PMID: 8270117

Source DB:  PubMed          Journal:  Dev Biol Stand        ISSN: 0301-5149


  5 in total

1.  Role of cyclophilin A from brains of prion-infected mice in stimulation of cytokine release by microglia and astroglia in vitro.

Authors:  Déborah Tribouillard-Tanvier; James A Carroll; Roger A Moore; James F Striebel; Bruce Chesebro
Journal:  J Biol Chem       Date:  2011-12-16       Impact factor: 5.157

2.  Analysis of protein levels of 24 cytokines in scrapie agent-infected brain and glial cell cultures from mice differing in prion protein expression levels.

Authors:  Déborah Tribouillard-Tanvier; James F Striebel; Karin E Peterson; Bruce Chesebro
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

3.  Role of Erk1/2 activation in prion disease pathogenesis: absence of CCR1 leads to increased Erk1/2 activation and accelerated disease progression.

Authors:  Rachel A LaCasse; James F Striebel; Cynthia Favara; Lisa Kercher; Bruce Chesebro
Journal:  J Neuroimmunol       Date:  2008-04-08       Impact factor: 3.478

4.  Prion disease induced alterations in gene expression in spleen and brain prior to clinical symptoms.

Authors:  Hyeon O Kim; Greg P Snyder; Tyler M Blazey; Richard E Race; Bruce Chesebro; Pamela J Skinner
Journal:  Adv Appl Bioinform Chem       Date:  2008-09-07

5.  Gene expression alterations in brains of mice infected with three strains of scrapie.

Authors:  Pamela J Skinner; Hayet Abbassi; Bruce Chesebro; Richard E Race; Cavan Reilly; Ashley T Haase
Journal:  BMC Genomics       Date:  2006-05-16       Impact factor: 3.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.